This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Editor's Commentary - Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement April 21, 2011
EAU 2011 - Prostate cancer screening: Can it be improved with total testosterone levels? - Session Highlights April 21, 2011
EAU 2011 - Prostate cancer incidence and disease-specific survival in men participating in the ERSPC with an initial PSA under 3.0 ng/ml - Session Highlights April 21, 2011
Association of black race with follow-up of an abnormal prostate-specific antigen test - Abstract April 20, 2011
Repeat prostate biopsies predict location of index cancer in an active surveillance cohort - Abstract April 20, 2011
Role for stromal heterogeneity in prostate tumorigenesis - Abstract April 20, 2011
Hot flushes in prostatic cancer patients during androgen-deprivation therapy with monthly dose of degarelix or leuprolide - Abstract April 20, 2011
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib - Abstract April 20, 2011
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer - Abstract April 20, 2011
No evidence of XMRV in prostate cancer cohorts in the Midwestern United States - Abstract April 20, 2011
Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California - Abstract April 20, 2011
PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40! - Abstract April 20, 2011
EAU 2011 - Oncological outcomes of high-intensity focused ultrasound for localized prostate cancer in 880 consecutive patients - Session Highlights April 20, 2011
EAU 2011 - Race and treatment choice affect cancer specific and overall survival differently in 16,508 men with localized prostate cancer treated in Cancer Research Networks in the United States - Session Highlights April 20, 2011
EAU 2011 - The role of intraoperative frozen section analysis in bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy for clinically localized prostate cancer - Session Highlights April 20, 2011
EAU 2011 - Monolateral nerve sparing prostatectomy: Review of indications, functional and oncological outcomes - Session Highlights April 20, 2011
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-Year data from the TROG 96.01 randomised trial - Abstract April 19, 2011
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England - Abstract April 19, 2011
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer - Abstract April 19, 2011
Effect of urologists and medical oncologists on treatment of elderly men with stage IV prostate cancer - Abstract April 19, 2011
Page 1262 of 1287
  • Start
  • Prev
  • 1257
  • 1258
  • 1259
  • 1260
  • 1261
  • 1262
  • 1263
  • 1264
  • 1265
  • 1266
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free